Fifth Third Bancorp Regeneron Pharmaceuticals, Inc. Transaction History

Fifth Third Bancorp

  • $27.3 Billion
  • Q3 2024

A detailed history of Fifth Third Bancorp transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Fifth Third Bancorp holds 10,396 shares of REGN stock, worth $7.87 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
10,396
Previous 8,253 25.97%
Holding current value
$7.87 Million
Previous $8.67 Million 25.99%
% of portfolio
0.04%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024
BUY
$1024.09 - $1201.76 $2.19 Million - $2.58 Million
2,143 Added 25.97%
10,396 $10.9 Million
Q2 2024

Jul 22, 2024
SELL
$883.2 - $1071.19 $105,100 - $127,471
-119 Reduced 1.42%
8,253 $8.67 Million
Q1 2024

Apr 23, 2024
SELL
$902.69 - $993.35 $216,645 - $238,404
-240 Reduced 2.79%
8,372 $8.06 Million
Q4 2023

Jan 19, 2024
SELL
$775.18 - $881.7 $48,061 - $54,665
-62 Reduced 0.71%
8,612 $7.56 Million
Q3 2023

Oct 31, 2023
BUY
$692.45 - $844.37 $9,001 - $10,976
13 Added 0.15%
8,674 $7.14 Million
Q2 2023

Jul 25, 2023
BUY
$700.03 - $830.35 $124,605 - $147,802
178 Added 2.1%
8,661 $6.22 Million
Q1 2023

Apr 24, 2023
SELL
$680.49 - $826.97 $202,105 - $245,610
-297 Reduced 3.38%
8,483 $6.97 Million
Q4 2022

Jan 25, 2023
BUY
$705.89 - $766.39 $33,176 - $36,020
47 Added 0.54%
8,780 $0
Q3 2022

Oct 25, 2022
BUY
$573.97 - $724.32 $110,202 - $139,069
192 Added 2.25%
8,733 $6.02 Million
Q2 2022

Aug 04, 2022
SELL
$548.35 - $738.84 $2.35 Million - $3.16 Million
-4,279 Reduced 33.38%
8,541 $5.05 Million
Q1 2022

Apr 19, 2022
SELL
$595.12 - $698.43 $200,555 - $235,370
-337 Reduced 2.56%
12,820 $8.95 Million
Q4 2021

Feb 01, 2022
BUY
$543.48 - $670.97 $378,805 - $467,666
697 Added 5.59%
13,157 $8.31 Million
Q3 2021

Oct 15, 2021
BUY
$574.03 - $680.96 $2.29 Million - $2.71 Million
3,983 Added 46.99%
12,460 $7.54 Million
Q2 2021

Aug 06, 2021
SELL
$472.8 - $558.54 $5.4 Million - $6.38 Million
-11,425 Reduced 57.41%
8,477 $4.74 Million
Q1 2021

May 07, 2021
SELL
$446.73 - $548.2 $1.55 Million - $1.9 Million
-3,460 Reduced 14.81%
19,902 $9.42 Million
Q4 2020

Feb 16, 2021
SELL
$478.3 - $607.98 $1.42 Million - $1.8 Million
-2,965 Reduced 11.26%
23,362 $11.3 Million
Q3 2020

Nov 09, 2020
BUY
$544.75 - $658.21 $388,406 - $469,303
713 Added 2.78%
26,327 $14.7 Million
Q2 2020

Aug 05, 2020
BUY
$493.32 - $643.92 $3.8 Million - $4.97 Million
7,712 Added 43.08%
25,614 $16 Million
Q1 2020

May 05, 2020
SELL
$336.18 - $494.43 $6.16 Million - $9.06 Million
-18,317 Reduced 50.57%
17,902 $8.74 Million
Q4 2019

Feb 14, 2020
BUY
$274.13 - $376.51 $167,767 - $230,424
612 Added 1.72%
36,219 $13.6 Million
Q3 2019

Nov 14, 2019
BUY
$273.46 - $318.39 $6.37 Million - $7.42 Million
23,304 Added 189.42%
35,607 $9.88 Million
Q2 2019

Aug 07, 2019
BUY
$299.6 - $414.82 $3.54 Million - $4.9 Million
11,811 Added 2400.61%
12,303 $3.85 Million
Q1 2019

May 14, 2019
BUY
$372.08 - $439.57 $27,533 - $32,528
74 Added 17.7%
492 $202,000
Q4 2018

Feb 14, 2019
SELL
$335.82 - $403.04 $167,238 - $200,713
-498 Reduced 54.37%
418 $156,000
Q3 2018

Nov 14, 2018
BUY
$351.14 - $408.51 $34,411 - $40,033
98 Added 11.98%
916 $370,000
Q2 2018

Aug 14, 2018
SELL
$284.6 - $344.99 $16,222 - $19,664
-57 Reduced 6.51%
818 $282,000
Q1 2018

May 15, 2018
BUY
$315.82 - $393.78 $138,013 - $172,081
437 Added 99.77%
875 $301,000
Q4 2017

Feb 14, 2018
BUY
$358.63 - $469.95 $24,745 - $32,426
69 Added 18.7%
438 $165,000
Q3 2017

Nov 14, 2017
SELL
$431.38 - $504.0 $5,176 - $6,048
-12 Reduced 3.15%
369 $165,000
Q2 2017

Aug 11, 2017
BUY
N/A
381
381 $187,000

Others Institutions Holding REGN

# of Institutions
1,529
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email